文献速递鼻科

肥胖与慢性鼻窦炎患者的临床免疫学特征评估

Assessing the clinico-immunological profile of patients with obesity and chronic rhinosinusitis.
PubMed 文献 · Int Forum Allergy Rhinol · 2023-11-23

本研究为克利夫兰诊所的前瞻性观察研究,纳入54例慢性鼻窦炎(CRS)患者,评估肥胖对临床和细胞因子特征的影响及功能性内镜鼻窦手术的疗效。肥胖CRS患者全身警报素IL-33和TSLP水平较非肥胖者低,伴鼻息肉且BMI≥30 kg/m2者术后鼻窦结局测试评分更高、鼻内嗜酸性粒细胞趋化因子-3和IL-33更低。结果可能提示存在独特的肥胖型2型低炎症CRS表型,需进一步探索。

要点

  • 肥胖CRS患者全身警报素IL-33和TSLP水平低于非肥胖CRS患者。
  • 伴鼻息肉且BMI≥30 kg/m2者术后鼻窦结局测试评分高于BMI<30 kg/m2者。
  • 伴鼻息肉且BMI≥30 kg/m2者鼻内嗜酸性粒细胞趋化因子-3和IL-33水平更低。

核心结论

  • 肥胖伴鼻息肉的CRS患者鼻内警报素和嗜酸性粒细胞趋化因子-3水平降低,可能提示独特的肥胖型2型低炎症CRS表型,需进一步探索。

研究设计与样本

  • 前瞻性观察研究,于克利夫兰诊所纳入2021年12月至2022年9月间的54例CRS患者。

主要发现

  • 54例CRS患者中,无鼻息肉20例(37%),伴鼻息肉34例(63%)。
  • 肥胖CRS患者全身IL-33为744.2 ± 1164.6 pg/mL,非肥胖CRS患者为137.5 ± 320.0 pg/mL(p = 0.005)。
  • 肥胖CRS患者全身TSLP为627.7 ± 1806.3 pg/mL,非肥胖CRS患者为28.1 ± 85.4 pg/mL(p = 0.017)。
  • 伴鼻息肉且BMI≥30 kg/m2的CRS患者术后鼻窦结局测试评分高于BMI<30 kg/m2者,鼻内嗜酸性粒细胞趋化因子-3和IL-33水平低于BMI<30 kg/m2者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: No studies have investigated the systemic and local sinonasal profile of obesity-related chronic rhinosinusitis (CRS), despite its observed association in recent retrospective studies. The objectives of our study were to assess the impact of obesity on the clinical and cytokine profile of patients with CRS and evaluate treatment response with functional endoscopic sinus surgery. METHODS: This was a prospective observational study at the Cleveland Clinic that included patients with CRS (n = 54) between December 2021 and September 2022. Data collection included demographics, body mass index (BMI), comorbidities, baseline sinonasal outcome test scores, baseline radiologic scores (Lund-Mackay), postoperative sinonasal outcome test scores (at 3-4 months), and local and systemic alarmins/T-helper cytokines. RESULTS: Out of the 54 CRS patients, there were 20 CRS patients without nasal polyps (37%) and 34 with nasal polyps (63%). Patients were categorized based on obesity (BMI ≥ 30 kg/m2). Obese CRS patients had lower systemic alarmins (interleukin [IL]-33 and Thymic stromal lymphopoietin (TSLP)) compared to non-obese CRS patients (IL-33: 744.2 ± 1164.6 pg/mL vs. 137.5 ± 320.0 pg/mL, p = 0.005; TSLP: 627.7 ± 1806.3 pg/mL vs. 28.1 ± 85.4 pg/mL, p = 0.017). CRS patients with nasal polyps with BMI ≥30 kg/m2 had higher postoperative sinonasal outcome test scores and lower levels of nasal eotaxin-3 and IL-33 compared to BMI <30 kg/m2 counterparts. CONCLUSIONS: In conclusion, patients with obese CRS and nasal polyps displayed diminished levels of intranasal alarmins and reduced intranasal eotaxin-3. These results potentially imply the presence of a unique, obese type 2-low CRS phenotype that warrants further exploration.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Chaaban MR, Asosingh K, Comhair S, et al. Assessing the clinico-immunological profile of patients with obesity and chronic rhinosinusitis. Int Forum Allergy Rhinol. 2023. PMID: 37997535. doi:10.1002/alr.23304

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。